. Author manuscript; available in PMC: 2014 Sep 19.

Published in final edited form as: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2

Analysis 4.29. Comparison 4 RISPERIDONE versus OLANZAPINE, Outcome 29 Adverse effects: 8a. Metabolic - cholesterol - significant cholesterol increase.

Review: Risperidone versus other atypical antipsychotics for schizophrenia

Comparison: 4 RISPERIDONE versus OLANZAPINE

Outcome: 29 Adverse effects: 8a. Metabolic - cholesterol - significant cholesterol increase